Cite
MLA Citation
Neil Chanchlani et al.. “Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.” Journal of Crohn's and colitis, vol. 16, 2022, pp. 389–397. http://access.bl.uk/ark:/81055/vdc_100151270361.0x000029